Gastrointestinal adverse events of metformin treatment in patients with type 2 diabetes mellitus: A systematic review, meta-analysis and meta-regression of randomized controlled trials

Overview of attention for article published in Frontiers in endocrinology, September 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (92nd percentile)
High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news: 3 news outlets

twitter: 4 X users

Citations

dimensions_citation: 16 Dimensions

Readers on

mendeley: 49 Mendeley

Summary News X Dimensions citations

So far, Altmetric has seen 3 news stories from 3 outlets.

Type 2 Diabetes Medications That Induce Weight Loss

Clinical Advisor, 29 Mar 2024

Credit: Our easy-to-read fact sheets provide patients with an overview for type 2 diabetes medications that also induce weight…

Type 2 Diabetes Medications That Induce Weight Loss

Endocrinology Advisor, 22 Mar 2024

Our easy-to-read fact sheets provide clinicians with reliable information to share with patients and their caregivers.

Metformin ups gastrointestinal adverse event risk in T2DM (of 10)

Pediatric News , 24 Oct 2022

Key clinical point: Patients with type 2 diabetes mellitus (T2DM) receiving metformin vs.

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.